抗疟疾标PfATP4的内源结构揭示了一种新的类型的阿皮复合体P型ATPase调节器
bioRxiv : the preprint server for biology
|March 10, 2025
概括
使用冷EM确定了Plasmodium falciparum (Pf ATP4) 的排泄结构. 发现了一种新的结合伙伴Pf ABP,为抗疟疾药物设计提供了新的策略.
科学领域:
- 结构生物学 结构生物学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 菌 (Plasmodium falciparum) 的排泄,Pf ATP4,是抗疟疾药物开发的关键目标.
- 对Pf ATP4的有限的高分辨率结构数据阻碍了新抑制剂的合理设计.
研究的目的:
- 为了确定Pf ATP4的高分辨率冷电子显微镜 (cryoEM) 结构.
- 确定Pf ATP4的新型结合伙伴,这些合作伙伴可以用于治疗干预.
主要方法:
- 从CRISPR工程的Plasmodium falciparum寄生虫中净化Pf ATP4. 通过CRISPR工程的Pf ATP4进行净化.
- 在3.7Å分辨率下确定Pf ATP4的冷EM结构.
主要成果:
- 成功地获得了Pf ATP4的3.7冷EM结构.
- 一个以前未知的复合素特异性结合伙伴,Pf ABP,被确定与Pf ATP4相互作用.
- Pf ABP与Pf ATP4形成了一种保守的相互作用,这表明它具有调节作用.
结论:
- 确定的Pf ATP4结构为其功能机制提供了关键的见解.
- 发现Pf ABP为开发下一代Pf ATP4抑制剂开辟了新的途径.
- 针对Pf ATP4-Pf ABP相互作用可能为疟疾治疗提供一种新的策略.
相关概念视频
ABC Transporters: Exporter
4.1K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.1K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Symbiosis
27.2K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
27.2K
Principles of Drug Action
5.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.7K
Viral Structure
61.5K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
61.5K


